Publications by authors named "Calvin R Sumner"

Claim this Profile
V
Vitamin B Supplementation in Psychiatric Practice.
Kevin P Kennedy, Jeanne L Alexander, Amir Garakani, Lawrence S Gross, David L Mintz, Calvin R Sumner

Curr Psychiatry Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.
Amir Garakani, Jeanne L Alexander, Calvin R Sumner, Janet H Pine, Lawrence S Gross

J Psychiatr Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?
Robyn P Thom, Jeanne L Alexander, David Baron, Amir Garakani, Lawrence Gross, Calvin R Sumner

J Psychiatr Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Gopalkumar Rakesh, Calvin R Sumner, Jeanne Leventhal Alexander, Lawrence S Gross, Janet Pine

J Nerv Ment Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric aspects of concussion.
Rajiv Radhakrishnan, Amir Garakani, Lawrence S Gross, Marcia K Goin, Janet Pine, Calvin R Sumner

Lancet Psychiatry· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings.
Benjamin W Lacy, David A Baron, Marcia K Goin, Lawrence S Gross, Andrew E Slaby, Calvin R Sumner

J Am Osteopath Assoc· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
Calvin R Sumner, Virginia S Haynes, Martin H Teicher, Jeffrey H Newcorn

Postgrad Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia.
Calvin R Sumner, Susan Gathercole, Michael Greenbaum, Richard Rubin, David Williams

Child Adolesc Psychiatry Ment Health· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.
Jeffrey H Newcorn, Virginia K Sutton, Margaret D Weiss, Calvin R Sumner

J Am Acad Child Adolesc Psychiatry· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study.
Rosalie J Bakken, Martin Paczkowski, Hal P Kramer, Alan A Axelson, David W Williams, Calvin R Sumner

Curr Med Res Opin· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.

J Child Adolesc Psychopharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.
Calvin R Sumner, Kory J Schuh, Virginia K Sutton, Robert Lipetz, Douglas K Kelsey

J Child Adolesc Psychopharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
Joseph A Johnston, Wenyu Ye, David L Van Brunt, Gerhardt Pohl, Calvin R Sumner

J Clin Psychopharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine.
Amy R Perwien, Douglas E Faries, Christopher J Kratochvil, Calvin R Sumner, Douglas K Kelsey

J Dev Behav Pediatr· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Douglas K Kelsey, Calvin R Sumner, Charles D Casat, Daniel L Coury, Humberto Quintana

Pediatrics· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis